NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.52
-0.65 (-6.39%)
At close: Jul 11, 2025, 4:00 PM
9.60
+0.08 (0.84%)
After-hours: Jul 11, 2025, 6:06 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $312.24 million as of July 11, 2025. Its market cap has increased by 61.75% in one year.
Market Cap
312.24M
Enterprise Value
319.13M
1-Year Change
61.75%
Ranking
Category
Stock Price
$9.52
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $312.24M, a decrease of -20.61%. That is a compound annual growth rate of -5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 312.24M | -6.51% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.68B |
| Johnson & Johnson | 376.17B |
| AbbVie | 339.59B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 272.76B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 228.91B |
| AstraZeneca | 223.49B |